SEC Form 4 · accession 0001209191-18-059277
Ra Medical Systems, Inc. · VTAK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Horwood
Officer — General Counsel
Period of report
Nov 16, 2018
Accepted (ET)
Nov 19, 2018 · 5:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001716621
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 16, 2018 | A | 27,641 | $0.00 | A | 27,641 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 1/3 of the total number of shares underlying the RSUs granted will vest on November 20, 2019, and 1/6th of the total number of shares underlying the RSUs will vest on each May 20 and November 20 thereafter, such that the Award will be fully vested on November 20, 2021; provided, however, that if a vesting date would otherwise fall on a day when the national stock exchange upon which the shares are listed is not open for trading, vesting will occur on the first trading day thereafter. Vesting in all instances is subject to the Reporting Person's continuous status as a Service Provider (as defined in the 2018 Equity Incentive Plan) through each vesting date.